Sep 29, 2020, 13:55 PM by Michael Croft

Bio-IT World Pharmaceutical breakthroughs and medical research comprise an immeasurably important chunk of the global healthcare industry, warranting an equally robust cybersecurity infrastructure. The healthcare industry is no stranger to the devices of cybercriminals who target hospitals, clinics, research institutions, and pharmaceutical companies in search of highly expensive personal health information to be sold on the darknet.

Sep 29, 2020, 09:25 AM by Michael Croft

SEOUL, SOUTH KOREA - Sep 29, 2020 - Standigm Inc. (“Standigm”), an artificial intelligence (AI)-based drug discovery company, and SK holdings C&C, Co

Sep 25, 2020, 11:05 AM by Michael Croft

Bio-IT World | A Canadian team shares a new mechanism of action for remdesivir, data science groups have computed consensomes (gene expression in the virus) and interactomes (potential molecular mechanisms of pathogenesis) and cryoEM images the spike protein. Plus, NIH funding for new vaccines and the Reliable Response Data Discovery consortium takes COVID-19 patient data questions.

Sep 24, 2020, 14:25 PM by Michael Croft

Bio-IT World Fecal microbiota transplantation (FMT), the idea of using fecal material from a healthy person to treat others who are sick, has been proposed for challenging conditions ranging from inflammatory bowel disease to autism and obesity. But to date, robust evidence from randomized clinical trials exists only for the use of FMT to treat recurrent C. difficile infection.

Sep 22, 2020, 03:05 AM by Michael Croft

Sep 18, 2020, 01:20 AM by Michael Croft

Bio-IT World New drug targets, reconstructing viral spread and lineage, monitoring mutations, reasons to focus on T-cell responses, DNA webs as culprits of tissue damage, a very tiny neutralizing agent, explaining paradoxical risk in people with obesity and diabetes, and the value of heparan. Plus, a new vaccine candidate heading to human trials, coronaviruses are being profiled, and a deep dive on how SARS-CoV-2 weakens the immune system.

Sep 17, 2020, 16:20 PM by Michael Croft

CARLSBAD, CA, UNITED STATES - Sep 17, 2020 - Jumpcode Genomics – a genome technology company founded by industry veterans in 2016 focused on improving the understanding of human disease – today exited stealth mode and announced the commercial launch of its CRISPRclean™ technology

Sep 17, 2020, 13:45 PM by Michael Croft

Bio-IT World Disease treatment through targeted protein degradation takes a range of approaches: from small molecules similar to thalidomide that act as “molecular glue” degraders to more advanced “beyond rule of 5” proteolysis-targeting chimeras (PROTACs) with bifunctional moieties that encourage protein interaction with its E3 ubiquitin ligase.

Sep 17, 2020, 09:49 AM by Michael Croft

BAR HARBOR, ME, UNITED STATES - Sep 17, 2020 - The MDI Biological Laboratory has announced that Romain Madelaine, Ph.D., has been appointed to the faculty as an assistant professor

Sep 17, 2020, 07:12 AM by Michael Croft

ROCHESTER, NY, UNITED STATES - Sep 17, 2020 - The Huntington Study Group (“HSG”), a world leader in clinical research for Huntington’s Disease (HD), announces a partnership with Prilenia Therapeutics, a clinical stage biotech company led by Michael R

Sep 16, 2020, 15:45 PM by Michael Croft

JENA, GERMANY - Sep 2, 2020 - Materials and Life Science researchers can now experience faster accessibility of deeper regions of interest when investigating samples in 3D

Sep 16, 2020, 11:51 AM by Michael Croft

RALEIGH, NC, UNITED STATES - Sep 16, 2020 - Fierce Healthcare released its annual Fierce Innovation Report this week, naming 2bPrecise the industry’s top clinical information management solution

Sep 16, 2020, 08:56 AM by Michael Croft

PHILADELPHIA, PA - Sep 16, 2020 - Imvax, Inc., an emerging oncology leader that is revolutionizing immunotherapy for patients with malignant glioblastomas (GBM) and other solid tumors with significant unmet medical needs, today announced the appointment of Wendy DiCicco to its board of directors

Sep 16, 2020, 01:20 AM by Michael Croft

Bio-IT World  The adoption of cloud technology in the life science industry has become increasingly pervasive as firms move forward with digital transformation initiatives aimed at creating operational efficiencies and delivering the next wave of biomedical innovations. As a result, cloud vendors are playing a more important role than ever before, especially for life sciences companies that produce FDA-regulated products.

Sep 15, 2020, 15:50 PM by Michael Croft

PHOENIX, AZ - Sep 15, 2020 - Accumen Inc. is helping healthcare get better, faster. Today the company launched its first software-as-a-service (SaaS) solution, MyBloodHealth®, a hospital-based telehealth anemia management program with both perioperative and comprehensive blood management options

Sep 15, 2020, 11:18 AM by Michael Croft

TORONTO, ON, CANADA - Sep 15, 2020 -  With advances in imaging technologies, new wearable health devices, mobile devices allowing patients to provide survey responses everywhere, and increasingly integrated electronic health records, health data consented for advancing biomedical research has never been more plentiful – or complex

Sep 15, 2020, 11:15 AM by Michael Croft

Bio-IT World VAST Data has launched its next generation storage architecture, LightSpeed, which combines the light-touch of VAST’s simple NAS appliance experience with leadership-class performance for GPU-based and AI Processor-based computing, taking the guesswork and configuration out of scaling up AI infrastructure.

Sep 15, 2020, 09:55 AM by Michael Croft

BOSTON, MA, UNITED STATES - Sep 15, 2020 - Kyruus, the leader in provider search and scheduling solutions for health systems, and Cerner Corporation, a global healthcare technology company, today announced that Adventist Health, a faith-based, nonprofit integrated health system serving the West Coast and Hawaii, has enhanced its digital consumer access experience with integrated technology solutions from the two companies

Sep 15, 2020, 09:42 AM by Michael Croft

REDCAR, UNITED KINGDOM - Sep 15, 2020 - Absolute Antibody Ltd., an industry-leading provider of recombinant antibody products and services, today announced the availability of the SeqPack™ Hybridoma Preservation Kit, which streamlines the sample submission process for hybridoma sequencing customers worldwide

Sep 15, 2020, 06:16 AM by Michael Croft

CARY, NC - Sep 15, 2020 - For Immediate ReleaseCATO SMS ACQUIRES ARRAY BIOSTATISTICSGlobal Provider Expands Specialized Clinical Research Offering with Enhanced Biostatistical ServicesCARY, Nx